Cardiovascular Disease Doctors in Cedar Park, TX Accepting Medicare

4 Cardiovascular Disease doctors found. Showing 1 - 4

Dr. Geoffrey Michael Crimmins, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1401 Medical Pkwy # B, Ste. 407, Cedar Park, TX 78613 Phone: 512-249-7190    Fax: 512-249-0438

Dr. Richard A Stoebner, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 801 E Whitestone Blvd Ste B, Cedar Park, TX 78613 Phone: 512-259-3467    Fax: 512-496-7303

Stuart Damore, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 910 E Whitestone Blvd, Cedar Park, TX 78613 Phone: 512-260-6100

Carl Carlino, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1401 Medical Pkwy # B, Suite 407, Cedar Park, TX 78613 Phone: 512-249-7190    Fax: 512-249-0348

News Archive

Regulus Therapeutics reports top-line results from RG-101 clinical study for HCV treatment

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").

PAREXEL launches marketing initiative to simplify journey from science to new treatments

As the global biopharmaceutical industry increasingly seeks to streamline the complex process of bringing new drugs to market, PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the launch of a new marketing initiative that highlights the Company's proven approach to help clients simplify the journey from science to new treatments.

Cipher Phase 3 dermatology study uses MedAvante Centralized Ratings

MedAvante, Inc., the leader in centralized expert evaluation of treatments for central nervous system disorders, announced that Cipher Pharmaceuticals is using MedAvante Centralized Ratings in their pivotal Phase 3 dermatology study.

Study outlines a baseline bundle of care interventions for critically ill patients

Critical illness results in millions of deaths globally every year, many of which could be avoided with basic, life-saving care. Now, a new study led by researchers at Karolinska Institutet in Sweden outlines a baseline bundle of care interventions that global experts agree should be available for all critically ill patients. The study, published in the journal BMJ Global Health, provides a blueprint for hospitals on how to reduce preventable deaths, including from COVID-19.

Vigorous exercise can slow down arthritis

Almost 60 percent of Americans age 65 and older suffer from some form of arthritis, a progressive joint disease which is the leading cause of disability in the United States. For more than 1 in 10 sufferers, arthritis makes simple, everyday tasks, from walking up a flight of stairs to bathing and dressing, extremely difficult and by 2010, the disease is expected to affect almost 40 million Americans over age 65, increasing the ranks of senior citizens with disabilities that limit independent living.

Read more Medical News

› Verified 2 days ago